Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
Seeking Alpha

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Business Wire

Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline

MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...
MarketWatch

Viral Vector Vaccines Strategic Business Research Report 2024-2030 | Expanding Pipeline of Infectious Disease Targets Strengthens the Commercial Outlook - ResearchAndMarkets.com

The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...